Home
Conditions
Orthomyxoviridae Infections

Clinical trial condition

Orthomyxoviridae Infections

Explore clinical trials studying Orthomyxoviridae Infections. Study availability and eligibility vary by location and protocol.

1,811 public trials 85 recruiting studies

Refine in advanced search Browse all conditions

Orthomyxoviridae Infections trial results

Completed

PregText: Feasibility of Monitoring Influenza Vaccine Safety in Pregnant Women Using Text Messaging

NCT01974050

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +5 more
Locations: Columbia University New York, United States

View Trial Details

Completed

Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers

NCT03459391

Conditions: Acute Respiratory Infection, Infections, Influenza, +6 more
Locations: SBEI HPE The First Moscow State Medical University n.a. Sechenov of Ministry of Health of Russian Federation, University Hospital #2, Department of Development of New Medicines Moscow, Russia

View Trial Details

Completed

Comparison of Laser Assisted Epidermal to Intradermal Administration of Seasonal Influenza Vaccine

NCT02988739

Conditions: Infections, Influenza in Human, Influenza, Human, +5 more
Locations: Medical University Vienna, University Clinic for Clinical Pharmacology Vienna, Austria

View Trial Details

Completed

Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly

NCT00386113

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

XC8 in the Treatment of Patients With Acute Respiratory Viral Infection

NCT03441373

Conditions: Acute Respiratory Infection, Infections, Influenza, +6 more
Locations: Udmurt Republic Budgetary Healthcare Institution "City clinical Hospital #9 of the Ministry of Health of the Udmurt Republic Izhevsk, Russia

State Educational Institution for further vocational education "Kazan State Medical Academy of Federal Healthcare Agency", Clinical site - State Independent Healthcare Institution "Republic Infectious Clinical Hospital n.a. professor Agafonov", Kazan', Russia

State Budgetary Institution of Higher Professional Education "Kuban State Medical University" of the Ministry of Health of the Russian Federation Krasnodar, Russia

Nizhegorodsky region SBHI Nizhniy Novgorod Infectious Regional Clinical Hospital № 2 Nizhny Novgorod, Russia

View all 18 locations

View Trial Details

Completed

A Study of Intravenous Zanamivir in the Treatment of Hospitalized Patients With Influenza Infection

NCT01527110

Conditions: Infections, Influenza, Human, Orthomyxoviridae Infections, +4 more
Locations: GSK Investigational Site Fukuoka, Japan

GSK Investigational Site Kanagawa, Japan

GSK Investigational Site Miyagi, Japan

GSK Investigational Site Miyagi, Japan

View Trial Details

Completed

Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)

NCT00964158

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: GSK Investigational Site Bilbao, Spain

GSK Investigational Site Burgos, Spain

GSK Investigational Site Madrid, Spain

GSK Investigational Site Móstoles/Madrid, Spain

View Trial Details

Completed

Assess the Safety and Immunogenicity of M-001 as A Standalone Influenza Vaccine and as A H5N1 Vaccine Primer in Adults

NCT02691130

Conditions: Healthy, Infections, Influenza, +6 more
Locations: St Istvan St laszlo Hospital Budapest, Hungary

View Trial Details

Completed

A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and Older

NCT02553343

Conditions: Infections, Influenza, Influenza, Human, +5 more
Locations: Milford, Connecticut, United States

Coral Gables, Florida, United States

Wichita, Kansas, United States

St Louis, Missouri, United States

View Trial Details

Completed

The Effect of Prophylactic Antipyretics on Immune Responses and Fever After 2014-2015 and 2015-2016 Inactivated Influenza Vaccine

NCT02212990

Conditions: Body Temperature Changes, Fever, Infections, +8 more
Locations: Duke University Health System Durham, North Carolina, United States

View Trial Details

Orthomyxoviridae Infections

Orthomyxoviridae Infections trial results

Related conditions